v3.26.1
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Components of Share-Based Compensation Expense Recognized
The following table reflects the components of share-based compensation expense recognized in our consolidated statements of operations (in millions):
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Stock options
$
12.8 
$
11.1 
$
24.3 
$
19.6 
RSUs
29.7 
26.0 
51.2 
49.4 
STAP awards
— 
— 
— 
(0.8)
ESPP
0.9 
0.7 
1.8 
1.4 
Total share-based compensation expense before tax
$
43.4 
$
37.8 
$
77.3 
$
69.6 
Schedule of Weighted-Average Assumptions to Measure the Fair Value of Stock Options
The following weighted average assumptions were used in estimating the fair value of stock options granted to employees during the six months ended June 30, 2026 and 2025:
June 30, 2026
June 30, 2025
Expected term of awards (in years)
5.0
5.0
Expected volatility
32.5 
%
32.2 
%
Risk-free interest rate
3.9 
%
4.1 
%
Expected dividend yield
0.0 
%
0.0 
%
Schedule of Activity and Status of Stock Options
A summary of the activity and status of stock options under the Prior Plan and the 2026 Plan during the six-month period ended June 30, 2026 is presented below:
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (in Years)
Aggregate
Intrinsic
Value (in millions)
Outstanding as of January 1, 2026
4,636,330 
$
166.11 
Granted
289,956 
536.12 
Exercised
(1,390,672)
139.97 
Forfeited
(565)
267.47 
Outstanding as of June 30, 2026
3,535,049 
$
206.72 
4.0
$
1,184.6 
Exercisable as of June 30, 2026
2,348,347 
$
143.57 
2.4
$
935.2 
Unvested as of June 30, 2026
1,186,702 
$
331.68 
6.9
$
249.4 
Schedule of Share-Based Compensation (Benefit) Expense Recognized
Total share-based compensation expense related to stock options was recorded as follows (in millions):
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Cost of sales
$
— 
$
— 
$
— 
$
— 
Research and development
0.1 
0.1 
0.2 
0.2 
Selling, general, and administrative
12.7 
11.0 
24.1 
19.4 
Share-based compensation expense before taxes
12.8 
11.1 
24.3 
19.6 
Related income tax benefit
(0.3)
(0.2)
(0.5)
(0.4)
Share-based compensation expense, net of taxes
$
12.5 
$
10.9 
$
23.8 
$
19.2 
Total share-based compensation expense related to RSUs was recorded as follows (in millions):
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Cost of sales
$
1.1 
$
1.1 
$
2.1 
$
2.1 
Research and development
10.3 
7.6 
15.2 
14.3 
Selling, general, and administrative
18.3 
17.3 
33.9 
33.0 
Share-based compensation expense before taxes
29.7 
26.0 
51.2 
49.4 
Related income tax benefit
(4.8)
(4.3)
(8.3)
(8.1)
Share-based compensation expense, net of taxes
$
24.9 
$
21.7 
$
42.9 
$
41.3 
Schedule of Stock Option Exercise Data
Stock option exercise data is summarized below (dollars in millions):
Three Months Ended
June 30,
Six Months Ended
June 30,
2026
2025
2026
2025
Number of options exercised
895,525 
138,526 
1,390,672 
270,000 
Cash received
$
126.3 
$
18.1 
$
194.6 
$
34.7 
Total intrinsic value of options exercised
$
378.5 
$
23.7 
$
561.4 
$
52.8 
Schedule of Restricted Stock Units Activity
A summary of the activity with respect to, and status of, RSUs during the six-month period ended June 30, 2026 is presented below:
Number of
RSUs
Weighted
Average
Grant Date
Fair Value
Unvested as of January 1, 2026
1,416,871 
$
252.86 
Granted
303,513 
521.14 
Vested
(279,842)
235.19 
Forfeited
(21,296)
279.83 
Unvested as of June 30, 2026
1,419,246 
$
313.31